Literature DB >> 19457302

[Radiotherapy in dermatology].

A Marín1, E Vargas-Díez, L Cerezo.   

Abstract

Ionizing radiation causes cell death through DNA damage and has a stronger effect on undifferentiated tumor cells with a high mitotic rate. The use of a fractionated radiotherapy regimen improves both efficacy and tolerance. In addition, greater fractionation, with lower doses per session, minimizes adverse effects. In the majority of tumors treated with radical radiotherapy, the tumor cells do not disappear immediately after treatment, and assessment of the final response to treatment before three months is premature. Radiotherapy is an important treatment modality in selected patients with skin cancer. Modern radiotherapy equipment and techniques achieve excellent rates of tumor control, associated with good cosmetic results, preserved function, and a low rate of complications. The choice of technique is determined by tumor size and site and the thickness. The techniques most widely used at the present time include external beam radiotherapy with linear accelerators and high-dose-rate brachytherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19457302     DOI: 10.1016/s0001-7310(09)70532-0

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  2 in total

1.  High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer.

Authors:  Angel Montero; Raúl Hernanz; Ana-Belén Capuz; Eva Fernández; Asunción Hervás; Rafael Colmenares; Alfredo Polo; Sonsoles Sancho; Rafael Molerón; Carmen Vallejo; Alfredo Ramos
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

2.  Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma.

Authors:  Rosa Ballester-Sánchez; Olga Pons-Llanas; Cristian Candela-Juan; Francisco Javier Celada-Alvarez; Blanca de Unamuno-Bustos; Margarita Llavador-Ros; Antonio Ballesta-Cuñat; Christopher A Barker; Alejandro Tormo-Mico; Rafael Botella-Estrada; Jose Perez-Calatayud
Journal:  J Contemp Brachytherapy       Date:  2015-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.